Home    Back

Béfizal    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
302Leber hereditary optic neuropathy1

302. Leber hereditary optic neuropathy    [ 20 clinical trials,   14 drugs,   (DrugBank: 4 drugs),   5 drug target genes,   32 drug target pathways]
Searched query = "Leber hereditary optic neuropathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 20 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04561466
(ClinicalTrials.gov)		March 26, 201914/3/2019Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic NeuropathyStudy of Efficacy of Befizal® 200 mg for the Treatment of Leber Hereditary Optic NeuropathySafety Issues;Efficacy, SelfDrug: BéfizalHôpital Necker-Enfants MaladesEuropean Georges Pompidou Hospital;CLAIROPRecruiting18 YearsN/AAll14Phase 2;Phase 3France